A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis
Public ClinicalTrials.gov record NCT00646035. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Prospective, Placebo-Controlled, Double-Blind, Randomized, Multi-Center Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine the safety and efficacy of paricalcitol capsules as compared to placebo for treatment of secondary hyperparathyroidism by decreasing serum intact parathyroid hormone levels in end stage renal disease subjects on peritoneal dialysis.
Study identification
- NCT ID
- NCT00646035
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2002 (Type not available)
- Primary completion
- Nov 2002 (Actual)
- Completion
- Not listed
- Last update posted
- Mar 28, 2008
Started 2002
United States locations
- U.S. sites
- 22
- U.S. states
- 16
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Los Angeles | California | 90095 | — |
| Not listed | Denver | Colorado | 80230 | — |
| Not listed | Washington D.C. | District of Columbia | 20007 | — |
| Not listed | Fort Myers | Florida | 33919 | — |
| Not listed | Tampa | Florida | 33603 | — |
| Not listed | Savannah | Georgia | 31405 | — |
| Not listed | Evanston | Illinois | 60201 | — |
| Not listed | Maywood | Illinois | 60153 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | New Orleans | Louisiana | 70112 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Las Vegas | Nevada | 89102 | — |
| Not listed | Mineola | New York | 11501 | — |
| Not listed | Cincinnati | Ohio | 45206 | — |
| Not listed | Cincinnati | Ohio | 45220 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Charleston | South Carolina | 29425 | — |
| Not listed | Memphis | Tennessee | 38105 | — |
| Not listed | Nashville | Tennessee | 37205 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Lubbock | Texas | 79430 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00646035, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2008 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00646035 live on ClinicalTrials.gov.